REGENXBIO Inc. (RGNX)

REGENXBIO Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, REGENXBIO stock has a consensus rating of "Buy" and an average price target of $24.18. The average 1-year stock price forecast is 244.94% higher than the current stock price, while the lowest is $10 (+42.65%) and the highest is $50 (+613.27%).

Price Target: $24.18 (+244.94%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10	$24.18	$19	$50
Change	+42.65%	+244.94%	+171.04%	+613.27%

Analyst Ratings

The average analyst rating for REGENXBIO stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	6	6	6	6	6	6
Buy	4	4	4	4	4	4
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mani Foroohar Leerink Partners	Leerink Partners	Buy Maintains $18 → $17	Buy	Maintains	$18 → $17	+142.51%	May 15, 2026
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Reiterates $16	Buy	Reiterates	$16	+128.25%	May 15, 2026
Annabel Samimy Stifel Nicolaus	Stifel Nicolaus	Buy Reiterates $42	Buy	Reiterates	$42	+499.14%	May 15, 2026
Luca Issi RBC Capital	RBC Capital	Buy Maintains $19	Buy	Maintains	$19	+171.04%	May 15, 2026
Paul Choi Goldman Sachs	Goldman Sachs	Hold Maintains $12 → $10	Hold	Maintains	$12 → $10	+42.65%	May 15, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

237.86M

Increased by 39.56%

from 170.44M

Revenue Next Year

286.45M

Increased by 20.43%

from 237.86M

EPS This Year

-2.55

from -3.76

EPS Next Year

-2.70

from -2.55

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	470.35M	112.72M	90.24M	83.33M	170.44M	237.86M	286.45M
Revenue Growth	204.30%	-76.03%	-19.94%	-7.66%	104.54%	39.56%	20.43%
EPS	2.91	-6.50	-6.02	-4.59	-3.76	-2.55	-2.70
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	408.5M	440.0M
Avg	237.9M	286.5M
Low	132.3M	146.6M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	139.6%	85.0%
Avg	39.6%	20.4%
Low	-22.4%	-38.4%

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	1.69	-0.25
Avg	-2.55	-2.70
Low	-4.77	-4.51

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.